IPO registrations (S-1, F-1) · Registrants
PANACOS PHARMACEUTICALS, INC.
- SEC CIK
- 1040017 · filings on EDGAR ↗
- Name on the registration
- V I TECHNOLOGIES INC
- Former names
- V I TECHNOLOGIES INC (1998–2005)
- Registration
- Form S-1, first filed 1998-02-26, last 1998-06-05; 1 initial registration, 5 amendments
- Outcome
- Final prospectus filed 1998-06-11
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 134 COOLIDGE AVE, Watertown, MA 02472
- EIN
- 11-3238476
- EDGAR entity type
- operating
- Insiders and CEO pay
- PANACOS PHARMACEUTICALS, INC. on the corporate pages
Offering terms
- Proposed price range
- $13.00–$15.00 per share (S-1/A filed 1998-06-05)
- Final price
- $12.00 per share, below the range (424B4 filed 1998-06-11, an initial public offering)
- Shares sold
- 3,000,000
- Gross proceeds
- $36,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol VITX
- Lead underwriters
- Cowen (960,000 shares)
- Syndicate
- UBS; SBC Warburg Dillon Read Inc (640,000); BT Alex. Brown (80,000); Oppenheimer (80,000); Donaldson, Lufkin & Jenrette (80,000); A.G. Edwards (80,000); Furman Selz (80,000); Hambrecht & Quist (80,000); Lehman Brothers (80,000); Morgan Stanley (80,000); Montgomery Securities (80,000); Prudential Securities (80,000); Citigroup (80,000); J.C. Bradford & Co (40,000); Crowell, Weedon & Co (40,000); FBR (40,000); Gerard Klauer Mattison & Co., LLC (40,000); Edward D. Jones & Co., LLC (40,000); Ladenburg Thalmann (40,000); KeyBanc Capital Markets (40,000); Parker/Hunter Incorporated (40,000); Pennsylvania Merchant Group (40,000); Piper Sandler (40,000); Raymond James (40,000); Truist Securities (40,000); Sutro & Co. Incorporated (40,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: PANACOS PHARMACEUTICALS, INC. EXACT (CIK (EXACT))
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1998-02-26 | S-1 | S-1 (registration) | V I TECHNOLOGIES INC | 0000950130-98-000911 ↗ |
| 1998-03-12 | S-1/A | S-1/A (amendment) | V I TECHNOLOGIES INC | 0000927016-98-000927 ↗ |
| 1998-04-08 | S-1/A | S-1/A (amendment) | V I TECHNOLOGIES INC | 0000927016-98-001426 ↗ |
| 1998-05-01 | S-1/A | S-1/A (amendment) | V I TECHNOLOGIES INC | 0000927016-98-001765 ↗ |
| 1998-05-11 | S-1/A | S-1/A (amendment) | V I TECHNOLOGIES INC | 0000950130-98-002537 ↗ |
| 1998-06-05 | S-1/A | S-1/A (amendment) | V I TECHNOLOGIES INC | 0000927016-98-002291 ↗ |
| 1998-06-11 | 424B4 | 424B4 (final prospectus) | V I TECHNOLOGIES INC | 0000950130-98-003054 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 1998-06-05 | S-1/A | registration statement | $13.00–$15.00 | 3,000,000 | - | Nasdaq VITX | 2 | from the submission text; range, shares headline, cover names 2 | document ↗ | |
| 1998-06-11 | 424B4 | final prospectus | $12.00 | 3,000,000 | $36,000,000 | Nasdaq VITX | 27 | from the submission text; price sentence, shares headline, proceeds computed, underwriting table 26, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Allaway Graham | Officer; OfficerOther | Chief Operating Officer; COO; COO & President | 25 | 2006–2008 | |
| ACKERMAN SAMUEL K | Director,Officer | President & CEO | 2 | 2006 | |
| FLETCHER R JOHN | Director | 4 | 2006–2008 | ||
| HAYWARD SURRY JEREMY | Director | 6 | 2006–2008 | ||
| HOOPER HERBERT H | Director | 3 | 2006–2007 | ||
| LERNER IRWIN | Director | 4 | 2006–2008 | ||
| LIMBER JOSEPH M | Director | 4 | 2006–2008 | ||
| LINSLEY ERIC W | Director | 3 | 2006–2007 | ||
| MARSHALL PEYTON J | Officer | CFO & Acting CEO; Chief Financial Officer | 6 | 2006–2007 | |
| Schmid Frederick | Officer | Senior VP, Comm Ops & Bus Dev | 6 | 2006–2008 | |
| Pelletier Robert | Officer | Acting Princ. Acctg Officer; Princ. Acctg Officer | 5 | 2006–2008 | |
| Fischer Laurent | Director | 5 | 2006–2008 | ||
| DUNTON ALAN W | Director,Officer | Chief Exec Officer & President; Chief Executive Officer | 9 | 2007–2008 | |
| RICHARDS JOHN D | Officer; Other | VP, Manufacturing Operations; VP- Manufacturing Operations | 4 | 2007–2008 | |
| Savage Robert G. | Director | 4 | 2007–2008 | ||
| Lategan Thomas | Officer | VP of Regulatory Affairs | 4 | 2007–2008 | |
| Martin David E. | Officer | Senior VP, Drug Development | 4 | 2007–2008 | |
| McCallister Scott | Officer | Chief Medical Officer | 4 | 2007–2008 | |
| Henderson Jane | Officer | Chief Financial Officer & CBO; Chief Financial Officer, CBO | 4 | 2008 | |
| CONUS PARTNERS INC | TenPercentOwner | 2 | 2009 | ||
| ZACKS ANDREW | TenPercentOwner | 2 | 2009 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | PANACOS PHARMACEUTICALS, INC. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), MA first:
- TRANSCEND THERAPEUTICS INC MA
- Eloxx Pharmaceuticals, Inc. MA
- CHARLES RIVER LABORATORIES INC MA
- AGENUS INC MA
- CURIS INC MA
- MOMENTA PHARMACEUTICALS INC MA
- ACCELERON PHARMA INC MA
- bluebird bio, Inc. MA
- Altus Pharmaceuticals Inc. MA
- BioVex Group, Inc. MA
In other datasets, the same topic (Health) in MA:
- Nonprofit: ABBIE M GRIFFIN HOSPITAL FUND (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health